Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 151NIH 19NETWORK 15INDUSTRY 3OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 267Triple Negative Breast Neoplasms 18Neoplasms 9Lymphedema 9Motor Activity 8Breast Cancer Lymphedema 8Breast Cancer Female 8Pathologic Complete Response 6Neoplasm Metastasis 6Colorectal Neoplasms 6Colonic Neoplasms 6Pain 5Fatigue 5Stomach Neoplasms 4Pain, Postoperative 4Recurrence 3Radiodermatitis 3Hereditary Breast and Ovarian Cancer Syndrome 3Endometrial Neoplasms 3Drug-Related Side Effects and Adverse Reactions 3Breast Diseases 3Advanced Breast Cancer 3Treatment Adherence and Compliance 2Thyroid Neoplasms 2Seroma 2Radiation Injuries 2Ovarian Neoplasms 2Melanoma 2Lymphoma 2Lung Neoplasms 2

Interventions

Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiation Dose Hypofractionation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Breast Carcinoma In Situ × Breast × Clear all
NCT05318274 2026-03-23

Hypofractionated Radiation Therapy vs Standard Treatment in Breast Cancer.

Coordinación de Investigación en Salud, Mexico

Phase NA Active not recruiting
72 enrolled
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡